Rocket Pharmaceuticals (RCKT) Tops Q1 EPS by 3c

Rocket Pharmaceuticals (NASDAQ: RCKT) reported Q1 EPS of ($0.56), $0.03 better than the analyst estimate of ($0.59).

For earnings history and earnings-related data on Rocket Pharmaceuticals (RCKT) click here.

You May Also Be Interested In

• JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
• JPMorgan Starts Multi Commodity Exchange of India Ltd (MCX:IN) at Underweight
• Japan's Katayama, Us Treasury's Bessent Hold Online Talks, Source Says - Reuters